cystadrops 3,8 mg/ml kapljice za oko, raztopina
orphan europe s.a.r.l. - merkaptamin - kapljice za oko, raztopina - merkaptamin 3,8 mg / 1 ml - merkaptamin
doptelet
swedish orphan biovitrum ab (publ) - avatrombopag maleate - trombocitopenija - antihemoragije - doptelet je primerna za zdravljenje hude trombocitopenije pri odraslih bolnikih s kronično bolezen jeter, ki so načrtovani, da opravijo invaziven postopek. doptelet is indicated for the treatment of primary chronic immune thrombocytopenia (itp) in adult patients who are refractory to other treatments (e. kortikosteroidi, imunoglobulini).
sugammadex amomed
aop orphan pharmaceuticals gmbh - sugammadex sodium - neuromuskularna blokada - vsi drugi terapevtski izdelki - zavrnitev nevromuskularne blokade, ki jo inducira rocuronium ali vecuronium. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
filsuvez
amryt pharmaceuticals dac - dry extract from birch bark (der 5-10 : 1), extraction solvent n-heptane 95% (w/w) - epidermolysis bullosa dystrophica; epidermolysis bullosa, junctional - priprave za zdravljenje ran in razjed - treatment of partial thickness wounds associated with dystrophic and junctional epidermolysis bullosa (eb) in patients 6 months and older.
empesin 40 i.e./2 ml koncentrat za raztopino za infundiranje
argipresin - koncentrat za raztopino za infundiranje - argipresin 40 i.e. / 2 ml - vazopresin (argipresin)
heplisav b
dynavax gmbh - površinski antigen hepatitisa b - hepatitis b - cepiva - heplisav b is indicated for the active immunisation against hepatitis b virus infection (hbv) caused by all known subtypes of hepatitis b virus in adults 18 years of age and older. the use of heplisav b should be in accordance with official recommendations. it can be expected that hepatitis d will also be prevented by immunisation with heplisav b as hepatitis d (caused by the delta agent) does not occur in the absence of hepatitis b infection.
naloxon orpha 0,4 mg
raztopina za injiciranje - nalokson
elocta 1500 i.e. prašek in vehikel za raztopino za injiciranje
swedish orphan biovitrum ab (publ) - efmoroktokog alfa - prašek in vehikel za raztopino za injiciranje - efmoroktokog alfa 1500 i.e. / 1 viala - koagulacijski faktor viii
elocta 250 i.e. prašek in vehikel za raztopino za injiciranje
swedish orphan biovitrum ab (publ) - efmoroktokog alfa - prašek in vehikel za raztopino za injiciranje - efmoroktokog alfa 250 i.e. / 1 viala - koagulacijski faktor viii
elocta 500 i.e. prašek in vehikel za raztopino za injiciranje
swedish orphan biovitrum ab (publ) - efmoroktokog alfa - prašek in vehikel za raztopino za injiciranje - efmoroktokog alfa 500 i.e. / 1 viala - koagulacijski faktor viii